Sclerosis multiplex (SM): vizsgálatok itt: Szlovénia
1 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleNon-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis
- Where
- Ljubljana
- Életkor
- 18 év and over
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07827586